Trimoryn Disclaimer: The Limits On Everything Published Here

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

That sentence is printed on the Trimoryn bottle and it appears in the footer of every page on this website. It is worth understanding rather than skipping. The FDA does not approve dietary supplements before they are sold. It regulates what they may claim, and a claim that a product affects a disease turns it into an unapproved drug. That is why the bottle prints support lines about processes rather than promises about conditions. The FDA's own questions and answers on dietary supplements is the plain-language version of the same point, and the NIH consumer sheet on dietary supplements is the one worth reading before buying anything in this aisle from anybody.

The corollary matters as much. A supplement that has not been evaluated is not thereby unsafe, and a supplement that has been registered is not thereby approved. Both readings are common and both are wrong, and the quality page takes the seals one at a time on exactly that basis.

No trial of the finished formula exists. Every paper cited on this website studied a single ingredient, in a population that was not Trimoryn buyers, usually at an amount larger than one capsule carries. That is the ordinary situation for a multi-ingredient supplement and it is stated here rather than obscured by citation density.

Several of the strongest citations here are null results. The eight-week glucomannan trial found no weight loss at 3.99 grams a day. The resveratrol absorption study found almost no unchanged resveratrol in plasma after a 25 mg dose. The curcumin pharmacokinetic study found serum curcumin undetectable or very low after 2 g without piperine. Those are cited because they are true.

Amounts on this panel are frequently below the amounts studied. Six of the eleven entries can be compared directly with a cited dose, and the dosage section prints all six comparisons in one table rather than scattering them.

Every citation was fetched, not remembered. Each identifier was pulled from the publisher's own record and each was swept twice for retractions, once by record and once by author. Five otherwise clean papers were dropped on the author sweep and replaced.

Lot TRI-26/GO-2941 and certificate reference TRI-2941-26-GO are label references. A lot code identifies a production run so that a complaint can be matched to a batch. It is not a purity test, not a potency test and not a contamination screen, and no lot-specific certificate of analysis for this product is published anywhere this desk can see.

The ten marks on the packaging are described one at a time on the quality page. Two of them are meaningful statements about a factory. One, the physician-formulated mark, names no clinician anywhere. None of the ten is a test of the powder in your bottle.

NCCIH on using dietary supplements wisely and the NIH fact sheet on weight-loss supplements are both worth reading before buying anything in this category, from anybody.

A reader arriving here from the seller’s order page will meet claims that do not appear on these pages. That gap is deliberate and it is worth naming rather than leaving to be noticed.

• “Supports calorie burn and thermogenesis.” On a marketing composite shipped with the product. Not on the bottle, and there is no thermogenic ingredient on this panel: no caffeine, no capsaicin, no green tea extract.
• “Claim up to $780 off” and three saving figures. Arithmetic against a comparison price this desk has never seen a bottle sold at, so no saving figure appears here.
• A higher review aggregate. The seller publishes 4.7 from 983 reviews. This desk publishes 4.5 from 1,190 of its own. Two populations, both printed, neither merged into the other.
• An audience narrower than the label. The order page is written for women over forty. The bottle restricts by age and by condition and says nothing about sex.

None of those is an accusation. A seller may describe its own product in its own words, and the FTC's health products compliance guidance is where the limits on that sit. What this desk can do is say which words are the label’s, which are the seller’s and which are its own, every time it uses any of them.